SEARCH

SEARCH BY CITATION

References

  • 1
    Isaacs D. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For). J. Paediatr. Child Health 2006; 42: 5447.
  • 2
    Efron D. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against). J. Paediatr. Child Health 2006; 42: 54851.
  • 3
    UNICEF. First Call for Children. World Declaration and Plan of Action from the World Summit for Children. Convention on the rights of the child. New York: UNICEF, 2000.
  • 4
    Volk HE, Neuman RJ, Todd RD. A systematic evaluation of ADHD and comorbid psychopathology in a population-based twin sample. J. Am. Acad. Child Adolesc. Psychiatry 2005; 44: 768.
  • 5
    The MTA Cooperative Group. A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal treatment of children with ADHD. Arch. Gen. Psychiatry 1999; 56: 107386.
  • 6
    The MTA Cooperative Group. Moderators and Mediators of treatment response for children with attention-deficit/Hyperactivity Disorder. Arch. Gen. Psychiatry 1999; 56: 108896.
  • 7
    Gunasekera H, Buckmaster A. Training in general paediatrics: is it time for change? J. Paediatr. Child Health 2004; 40: 5106.